Stay updated on Phase II Nivolumab and Ramucirumab for Mesothelioma Clinical Trial

Sign up to get notified when there's something new on the Phase II Nivolumab and Ramucirumab for Mesothelioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Nivolumab and Ramucirumab for Mesothelioma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Updated page revision from v3.0.1 to v3.0.2; removed the Back to Top element.
    Difference
    0.2%
    Check dated 2025-09-14T22:13:27.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.2%
    Check dated 2025-09-07T19:37:50.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has been updated to include a new facility name and location, along with a list of relevant publications from PubMed related to malignant mesothelioma. Several previous terms and topics have been removed, including specific drug categories and related topics.
    Difference
    5%
    Check dated 2025-08-31T12:28:01.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T04:44:15.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-10T00:35:12.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.8%
    Check dated 2025-08-02T19:32:20.000Z thumbnail image

Stay in the know with updates to Phase II Nivolumab and Ramucirumab for Mesothelioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Nivolumab and Ramucirumab for Mesothelioma Clinical Trial page.